NCT06470841Not yet recruitingPhase 2
CHG Combined With Venetoclax and Azacytidine in Newly Diagnosed AML
CHG Regimen Combined With Venetoclax and Azacytidine in Newly Diagnosed Acute Myeloid Leukemia
Source: ClinicalTrials.gov · Last updated 22 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this phase 2 trial is to test the safety and efficacy of CHG Combined With Venetoclax in treating patients with newly diagnosed AML.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 85 (estimated)
- First submitted
- 17 Jun 2024
- Start date
- 20 Sept 2024
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Navy General Hospital, Beijing
- Diseases
- Acute myeloid leukemia
- NCT number
- NCT06470841
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 85
- From 20 Sept 2024 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Active or uncontrolled infections requiring systemic treatment within 14 days before enrollment.
Other illness
- Any instability of systemic disease, including but not limited to severe cardiac, liver, kidney, or metabolic disease need therapy.
Other
- Pregnant or lactating women.
Who the study is looking for
- The patient should, in the investigator's opinion, be able to meet all clinical trial requirements.
- The patient is willing and able to adhere to the study visit schedule and other protocol requirements.
- The patient should be diagnosed with AML according to the standard criteria of the World Health Organisation (WHO).
- The patient should not have received any prior treatment for AML.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Navy General Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.